Why Premium Condoms Risk Extinction in India
Are condoms "essential medicine"? A court verdict on that will now decide whether premium condoms will soon go off the shelves in India, with the national drug regulator capping the price of the male contraceptive at Rs 8.04 apiece in an order last week. Â
Major condom manufacturers - who have moved court against the cap on condom prices - are also worried about a clause in the new notification issued by the National Pharmaceutical Pricing Authority or NPPA. It says, "The manufacturer not complying with the ceiling price and notes specified hereinabove in this notification, shall be liable to deposit overcharged amount along with the interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with the Essential Commodities Act, 1955.
"If the court rules in favour of the government, we will have no choice but to follow the ceiling price. However, there is no clarity if there will be any retrospective penalty levied on us (for continuing to sell above the capped prices till the verdict)," a senior official from TTK Protective Devices told NDTV.
The Chennai-based TTK Protective Devices, which manufactures the 'Skore' brand of condoms, has moved the Madras High Court with a plea to take condoms off the essential medicine list.
The government had in May last year, included condoms in that list and had fixed the ceiling price at Rs 6.50 per piece in a Drug Pricing Control Order (DPCO) issued in November 2013, forcing manufacturers to go to court.
Now the regulator has said, "The manufacturers of above mentioned scheduled formulations (condoms) having maximum retail price higher than the ceiling price...shall revise the MRP (maximum retail price) to an amount not exceeding the ceiling price plus local taxes, wherever applicable."
The revision in the ceiling price brings no relief for manufacturers, who right now sell premium condoms at an average price of Rs 16 to Rs 20 per piece.
Some, like Durex RealFeel condoms cost as much as Rs 50 per piece. Online shopping portal condombazaar.com sells a pack of six Durex RealFeel for Rs 280.
Manufacturers say the regulator's move will ensure that textured, flavoured or scented condoms are not available anymore in India as they will find it difficult to produce these premium varieties while maintaining margins.
Apart from TTK, Reckitt Benckiser, the company that manufactures Durex, has approached the Delhi High Court challenging the regulator's order. The company refused to comment as the matter is sub-judice.
Â
Companies that manufacture premium condoms include Reckitt Benckiser (Durex, Kohinoor), TTK Protective Devices (Skore), JK Ansell (KamaSutra), and Mankind (Manforce).
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets